These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 21320544)
21. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague. Sun W; Olinzock J; Wang S; Sanapala S; Curtiss R Pathog Dis; 2014 Mar; 70(2):119-31. PubMed ID: 23913628 [TBL] [Abstract][Full Text] [Related]
23. Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine. Airhart CL; Rohde HN; Hovde CJ; Bohach GA; Deobald CF; Lee SS; Minnich SA Vaccine; 2008 Oct; 26(44):5554-61. PubMed ID: 18722493 [TBL] [Abstract][Full Text] [Related]
24. Rational considerations about development of live attenuated Yersinia pestis vaccines. Sun W; Curtiss R Curr Pharm Biotechnol; 2013; 14(10):878-86. PubMed ID: 24372254 [TBL] [Abstract][Full Text] [Related]
25. Live-attenuated Yersinia pestis vaccines. Wang X; Zhang X; Zhou D; Yang R Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796 [TBL] [Abstract][Full Text] [Related]
26. A Recombinant Attenuated Singh AK; Curtiss R; Sun W Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960 [TBL] [Abstract][Full Text] [Related]
27. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague. Sanapala S; Rahav H; Patel H; Sun W; Curtiss R Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051 [TBL] [Abstract][Full Text] [Related]
28. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. Branger CG; Fetherston JD; Perry RD; Curtiss R Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine. Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803 [TBL] [Abstract][Full Text] [Related]
30. Yersinia pestis caf1 variants and the limits of plague vaccine protection. Quenee LE; Cornelius CA; Ciletti NA; Elli D; Schneewind O Infect Immun; 2008 May; 76(5):2025-36. PubMed ID: 18347051 [TBL] [Abstract][Full Text] [Related]
31. Oral vaccination against plague using Yersinia pseudotuberculosis. Demeure CE; Derbise A; Carniel E Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452 [TBL] [Abstract][Full Text] [Related]
32. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice. Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022 [TBL] [Abstract][Full Text] [Related]
33. A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model. Zhang X; Qi Z; Du Z; Bi Y; Zhang Q; Tan Y; Yang H; Xin Y; Yang R; Wang X Vaccine; 2013 May; 31(22):2539-42. PubMed ID: 23588087 [TBL] [Abstract][Full Text] [Related]
34. A dam mutant of Yersinia pestis is attenuated and induces protection against plague. Robinson VL; Oyston PC; Titball RW FEMS Microbiol Lett; 2005 Nov; 252(2):251-6. PubMed ID: 16188402 [TBL] [Abstract][Full Text] [Related]
35. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice. Torres-Escobar A; Juárez-Rodríguez MD; Gunn BM; Branger CG; Tinge SA; Curtiss R Infect Immun; 2010 Jun; 78(6):2529-43. PubMed ID: 20308296 [TBL] [Abstract][Full Text] [Related]
36. Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection. Singh AK; Wang X; Sun W Vaccine; 2020 May; 38(21):3720-3728. PubMed ID: 32278523 [TBL] [Abstract][Full Text] [Related]
37. Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice. Wang S; Joshi S; Mboudjeka I; Liu F; Ling T; Goguen JD; Lu S Vaccine; 2008 Mar; 26(13):1664-74. PubMed ID: 18291562 [TBL] [Abstract][Full Text] [Related]
39. Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague. Davies ML; Biryukov SS; Rill NO; Klimko CP; Hunter M; Dankmeyer JL; Miller JA; Shoe JL; Mlynek KD; Talyansky Y; Toothman RG; Qiu J; Bozue JA; Cote CK Front Immunol; 2024; 15():1397579. PubMed ID: 38835755 [TBL] [Abstract][Full Text] [Related]
40. High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay. Li B; Zhou L; Guo J; Wang X; Ni B; Ke Y; Zhu Z; Guo Z; Yang R Infect Immun; 2009 Oct; 77(10):4356-61. PubMed ID: 19651863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]